These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [The effect of D-penicillamine on the galactosamine hepatitis model in the rat]. Habersang S, Kozlik V, Leuschner F, von Schlichtegroll A. Arzneimittelforschung; 1973 Jan; 23(1):56-7. PubMed ID: 4740696 [No Abstract] [Full Text] [Related]
13. Protective effects of azathioprine and phenobarbital on acute liver damage produced by galactosamine. Perings E, Brunner G, Vido I, Söling HD, Creutzfeldt W. Acta Hepatogastroenterol (Stuttg); 1973 Jan; 20(2):130-4. PubMed ID: 4148023 [No Abstract] [Full Text] [Related]
16. [Pharmacodynamics, site and mechanism of action of silymarin, the antihepatoxic principle from Silybum mar. (L) Gaertn. 1. Acute toxicology or tolerance, general and specific (liver-) pharmacology]. Vogel G, Trost W, Braatz R, Odenthal KP, Brüsewitz G, Antweiler H, Seeger R. Arzneimittelforschung; 1975 Jan; 25(1):82-9. PubMed ID: 1173772 [No Abstract] [Full Text] [Related]
17. Effect of silymarin on experimental liver lesions. Barbarino F, Neumann E, Deaciuc I, Ghelberg NW, Suciu A, Cotuţiu C, Racoviţă L, Stroilă C, Nagy S, Părău N, Toader S, Brilinschi C. Med Interne; 1981 Jan; 19(4):347-57. PubMed ID: 7336095 [Abstract] [Full Text] [Related]
19. An investigation of the hepatotoxicity of D-galactosamine in different species of animal. James GW, Pickering RW, Parker FL. Arzneimittelforschung; 1975 Oct; 25(10):1593-4. PubMed ID: 1243045 [Abstract] [Full Text] [Related]